
A drug is called “orphan” when it is intended for treating rare diseases. This situation deters the pharmaceutical industries from investing in this kind of products.
INTERNATIONAL NETWORK OF LAW AND CONSULTING FIRMS
A drug is called “orphan” when it is intended for treating rare diseases. This situation deters the pharmaceutical industries from investing in this kind of products.